Aastrom planning follow-on

Aastrom Biosciences Inc. (NASDAQ:ASTM) said late Thursday it is planning a follow-on underwritten by Stifel Nicolaus Weisel; Needham; and Roth Capital Partners. Aastrom's expanded autologous mixed cel...